Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

Key value for chemical safety assessment

Bioaccumulation potential:
low bioaccumulation potential
Absorption rate - oral (%):
50
Absorption rate - dermal (%):
50
Absorption rate - inhalation (%):
100

Additional information

There are no published data which could be identified on the toxicokinetics of the substance. However, as per REACH guidance document R7. C (June 2017), information on absorption, distribution, metabolism and excretion may be deduced from the physico-chemical properties including:

-       Water solubility

-       Partition coefficient

-       Vapour pressure

-       Molecular weight

 

Oral absorption

Based on physico-chemical properties:

According to the REACH guidance document R7.C (June, 2017), oral absorption is maximal for substances with molecular weights below 500. Water-soluble substances will readily dissolve into the gastrointestinal fluids; however absorption of hydrophilic substances via passive diffusion may be limited by the rate at which the substance partitions out of the gastrointestinal fluid. Further, absorption by passive diffusion is higher at moderate log Kow values (between -1 and 4). If signs of systemic toxicity are seen after oral administration (other than those indicative of discomfort or lack of palatability of the test substance), then it could be assumed that absorption has occurred to some extent.

The test substance is a mono-constituent with a molecular weight (MW) below 500 g/mol. It is a liquid with a high water solubility >1 g/L and an experimental log Kow of 1.15. Volatility was determined to be low (based on vapour pressure of 10.3 Pa at 20°C).

Based on the R7.C indicative criteria, oral uptake of the test substance is assessed to be high, given the low MW and high water solubility.

Conclusion: Overall, based on all the available weight of evidence, the test substance can be expected to have a high absorption through the oral route. However, in absence of experimental data, a default value of 50% has been considered for the risk assessment.

 

Dermal absorption

Based on physico-chemical properties:

According to REACH guidance document R7.C (May 2014), dermal absorption is maximal for substances with molecular weights below 500 and log Kow values ranging between 1 and 4. The test substance has MW below 500 g/mol and the measured log Kow of the test substance is 1.15. Therefore, along with the high water solubility, this suggests that the substance has a moderate skin penetration potential.

Conclusion: Physico-chemical properties and QSAR predictions suggest that the test substance will be absorbed moderately via skin. However, a default value of 50% (no higher than oral uptake) has been assumed for a conservative risk assessment.

 

Inhalation absorption

Based on physico-chemical properties:

According to REACH guidance document R7.C (May 2014), inhalation absorption is maximal for substances with VP >25 KPa, particle size (<100 μm), low water solubility and moderate log Kow values (between -1 and 4). Very hydrophilic substances may be retained within the mucus and not available for absorption.

The test substance, because of its low vapour pressure (10.3 Pa at 20°C), moderate log Kow (1.15) and high water solubility (>1 g/L), will not be available as vapour for inhalation under ambient conditions.

Conclusion: Overall, based on all the available weight of evidence, the test substance can be expected to have low absorption through the inhalation route. However, in absence of experimental data, a default value of 100% has been considered for the risk assessment.

 

Metabolism

Based on QSAR modelling:

The predicted metabolism of the test substance was evaluated using the in vivo rat metabolism and rat liver S9 metabolism simulators of the OECD QSAR Toolbox v.3.4. According to these simulators, the test substance is predicted to undergo S - oxidation.

 

Bioaccumulation:

Based on the physico-chemical information (log Kow of 1.15) and BCF of 3.162 L/kg wet-wt, it is concluded that the potential of the test substance for bioaccumulation is low.

 

Excretion:

Based on the low MW and high water solubility, the test substance is expected to be excreted via urine.